Cargando…

Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome

BACKGROUND: Endocrine disorders are common in patients with 22q11.2 deletion syndrome (22q11.2DS). This study aimed to elucidate the clinical manifestations of endocrine disorders, including parathyroid, thyroid and growth disorders, in Taiwanese patients with 22q11.2DS. METHODS: From 1994 to 2020,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Han-Yi, Tsai, Wen-Yu, Tung, Yi-Ching, Liu, Shih-Yao, Lee, Ni-Chung, Chien, Yin-Hsiu, Hwu, Wuh-Liang, Lee, Cheng-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008307/
https://www.ncbi.nlm.nih.gov/pubmed/35432203
http://dx.doi.org/10.3389/fendo.2022.771100
_version_ 1784687023032893440
author Lin, Han-Yi
Tsai, Wen-Yu
Tung, Yi-Ching
Liu, Shih-Yao
Lee, Ni-Chung
Chien, Yin-Hsiu
Hwu, Wuh-Liang
Lee, Cheng-Ting
author_facet Lin, Han-Yi
Tsai, Wen-Yu
Tung, Yi-Ching
Liu, Shih-Yao
Lee, Ni-Chung
Chien, Yin-Hsiu
Hwu, Wuh-Liang
Lee, Cheng-Ting
author_sort Lin, Han-Yi
collection PubMed
description BACKGROUND: Endocrine disorders are common in patients with 22q11.2 deletion syndrome (22q11.2DS). This study aimed to elucidate the clinical manifestations of endocrine disorders, including parathyroid, thyroid and growth disorders, in Taiwanese patients with 22q11.2DS. METHODS: From 1994 to 2020, the medical records of 138 patients with 22q11.2DS diagnosed at a tertiary referral medical center in Taiwan were thoroughly reviewed retrospectively. RESULTS: Hypocalcemia was detected in 57 of 135 patients (42%); 33 of 104 patients (32%) had hypoparathyroidism, and in 87% of them, hypocalcemia was detected before the age of one. Most patients had precipitating stressors during symptomatic hypocalcemic episodes. Eighteen of 29 patients had overt hypoparathyroidism at the last visit: 11 had persistent hypoparathyroidism and the other seven had recurrent hypoparathyroidism. Four of 84 patients had thyroid disorders, including thyroid developmental anomalies in two, dyshormonogenesis in one and Graves’ disease in one. Fifty of 126 patients (40%) had short stature. Age (odds ratio (OR) 0.91; 95% confidence interval (CI) 0.86-0.96; P<0.001) and airway anomalies (OR 2.75; 95% CI 1.04-7.31; P<0.05) were significant risk factors for short stature in multivariate logistic regression model. Twenty-eight of the 30 patients with airway anomalies were associated with severe congenital heart disease. Adult height standard deviation score (SDS) in 19 patients was significantly lower than target height SDS (-1.15 ± 0.90 vs -0.08 ± 0.65, P<0.001). CONCLUSIONS: Hypoparathyroidism is a common endocrine disorder in patients with 22q11.2DS. It is prudent to assess parathyroid function at diagnosis and during follow-up, especially in the presence of stress, to prevent symptomatic hypocalcemia. Although thyroid disorders are not so common as hypoparathyroidism, screening of thyroid dysfunction is justified in these patients. Patients with 22q11.2DS demonstrate a retarded growth pattern with a tendency of catch-up and regular monitoring of growth is indicated.
format Online
Article
Text
id pubmed-9008307
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90083072022-04-15 Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome Lin, Han-Yi Tsai, Wen-Yu Tung, Yi-Ching Liu, Shih-Yao Lee, Ni-Chung Chien, Yin-Hsiu Hwu, Wuh-Liang Lee, Cheng-Ting Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Endocrine disorders are common in patients with 22q11.2 deletion syndrome (22q11.2DS). This study aimed to elucidate the clinical manifestations of endocrine disorders, including parathyroid, thyroid and growth disorders, in Taiwanese patients with 22q11.2DS. METHODS: From 1994 to 2020, the medical records of 138 patients with 22q11.2DS diagnosed at a tertiary referral medical center in Taiwan were thoroughly reviewed retrospectively. RESULTS: Hypocalcemia was detected in 57 of 135 patients (42%); 33 of 104 patients (32%) had hypoparathyroidism, and in 87% of them, hypocalcemia was detected before the age of one. Most patients had precipitating stressors during symptomatic hypocalcemic episodes. Eighteen of 29 patients had overt hypoparathyroidism at the last visit: 11 had persistent hypoparathyroidism and the other seven had recurrent hypoparathyroidism. Four of 84 patients had thyroid disorders, including thyroid developmental anomalies in two, dyshormonogenesis in one and Graves’ disease in one. Fifty of 126 patients (40%) had short stature. Age (odds ratio (OR) 0.91; 95% confidence interval (CI) 0.86-0.96; P<0.001) and airway anomalies (OR 2.75; 95% CI 1.04-7.31; P<0.05) were significant risk factors for short stature in multivariate logistic regression model. Twenty-eight of the 30 patients with airway anomalies were associated with severe congenital heart disease. Adult height standard deviation score (SDS) in 19 patients was significantly lower than target height SDS (-1.15 ± 0.90 vs -0.08 ± 0.65, P<0.001). CONCLUSIONS: Hypoparathyroidism is a common endocrine disorder in patients with 22q11.2DS. It is prudent to assess parathyroid function at diagnosis and during follow-up, especially in the presence of stress, to prevent symptomatic hypocalcemia. Although thyroid disorders are not so common as hypoparathyroidism, screening of thyroid dysfunction is justified in these patients. Patients with 22q11.2DS demonstrate a retarded growth pattern with a tendency of catch-up and regular monitoring of growth is indicated. Frontiers Media S.A. 2022-03-31 /pmc/articles/PMC9008307/ /pubmed/35432203 http://dx.doi.org/10.3389/fendo.2022.771100 Text en Copyright © 2022 Lin, Tsai, Tung, Liu, Lee, Chien, Hwu and Lee https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Lin, Han-Yi
Tsai, Wen-Yu
Tung, Yi-Ching
Liu, Shih-Yao
Lee, Ni-Chung
Chien, Yin-Hsiu
Hwu, Wuh-Liang
Lee, Cheng-Ting
Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome
title Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome
title_full Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome
title_fullStr Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome
title_full_unstemmed Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome
title_short Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome
title_sort endocrine and growth disorders in taiwanese children with 22q11.2 deletion syndrome
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008307/
https://www.ncbi.nlm.nih.gov/pubmed/35432203
http://dx.doi.org/10.3389/fendo.2022.771100
work_keys_str_mv AT linhanyi endocrineandgrowthdisordersintaiwanesechildrenwith22q112deletionsyndrome
AT tsaiwenyu endocrineandgrowthdisordersintaiwanesechildrenwith22q112deletionsyndrome
AT tungyiching endocrineandgrowthdisordersintaiwanesechildrenwith22q112deletionsyndrome
AT liushihyao endocrineandgrowthdisordersintaiwanesechildrenwith22q112deletionsyndrome
AT leenichung endocrineandgrowthdisordersintaiwanesechildrenwith22q112deletionsyndrome
AT chienyinhsiu endocrineandgrowthdisordersintaiwanesechildrenwith22q112deletionsyndrome
AT hwuwuhliang endocrineandgrowthdisordersintaiwanesechildrenwith22q112deletionsyndrome
AT leechengting endocrineandgrowthdisordersintaiwanesechildrenwith22q112deletionsyndrome